(Q28373544)

1

0 references

A Marfat

2

0 references

G W Antognoli

3

0 references

J B Cheng

4

0 references

D B Damon

5

0 references

A V Kuperman

6

0 references

T C Liston

7

0 references

C Mebus

8

0 references

J S Pillar

9

0 references

J T Shirley

10

0 references

J W Watson

Bioorganic & Medicinal Chemistry Letters

11

0 references

language of work or name

English

0 references

publication date

20 September 1999

0 references

published in

0 references

volume

9

0 references

issue

18

0 references

page(s)

2773-8

0 references

cites work

Leukotriene activity modulation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Development of new chromanol antagonists of leukotriene D4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Designing safer drugs based on the soft drug approach

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Serotonin receptor affinity of cathinone and related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Induction of peroxisomal enzymes by a tetrazole-substituted 2-quinolinylmethoxy leukotriene D4 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

H-ras 61st codon activation in archival proliferative hepatic lesions isolated from female B6C3F1 mice exposed to the leukotriene D4-antagonist, LY171883.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021

Hepatic peroxisome proliferation in rodents and its significance for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900461-8

7 January 2021